| RS2135828294 |
SHANK2
|
Health Risk |
Pathogenic |
— |
| RS2135828360 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135829327 |
COL13A1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS2135829844 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135829883 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135830163 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135831473 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135831491 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135832115 |
UBE3B
|
Health Risk |
Likely pathogenic |
Oculocerebrofacial syndrome, Kaufman type |
| RS2135832423 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832426 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832456 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135832474 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832527 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135832538 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 3 |
| RS2135832551 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135832560 |
SCYL2
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 4, neurogenic |
| RS2135832562 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832585 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832611 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832615 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832632 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 3 |
| RS2135832668 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832675 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832685 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832689 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, HNF1A-related disorder |
| RS2135832696 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 3 |
| RS2135832753 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832792 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135832798 |
SCYL2
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 4, neurogenic |
| RS2135832861 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135833005 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135833007 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2135833290 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135833480 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2135833743 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135834073 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135834102 |
TCTN2
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2135834179 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135834235 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135834746 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135834949 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2135835079 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135836123 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135836264 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135836328 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135836483 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135836491 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135837254 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2135837530 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2135838442 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2135838920 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2135839075 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135839114 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS2135839308 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135839346 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135839643 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young type 3 |
| RS2135839880 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2135839892 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135839897 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, HNF1A-related disorder |
| RS2135839973 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135839997 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135840135 |
TCTN2
|
Health Risk |
Pathogenic |
— |
| RS2135840297 |
MYRF
|
Health Risk |
Likely pathogenic |
Cardiac-urogenital syndrome, Cardiac-urogenital syndrome |
| RS2135840482 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135840945 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135840980 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS2135841104 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841113 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841224 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841238 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Monogenic diabetes |
| RS2135841315 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841381 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135841512 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841592 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 3 |
| RS2135841756 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135841769 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135841855 |
HNF1A
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135842256 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135842335 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young type 3 |
| RS2135842474 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135842587 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS2135842812 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135843880 |
MYRF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2135845255 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135845384 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135845768 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2135845908 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2135845949 |
HNF1A
|
Health Risk |
Pathogenic |
— |
| RS2135847098 |
EPS8
|
Health Risk |
Pathogenic |
— |
| RS2135847212 |
TCTN2
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS2135847311 |
HNF1A
|
Health Risk |
Likely pathogenic |
6 conditions, 6 conditions |
| RS2135847318 |
EPS8
|
Health Risk |
Pathogenic |
— |
| RS2135847381 |
HNF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young type 3 |
| RS2135847417 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young type 3 |
| RS2135847490 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135847592 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young type 3 |
| RS2135847863 |
HNF1A
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135848297 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2135849050 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |